☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Kiora Pharmaceuticals
Inherited Retinal Disease Management: Brian Strem from Kiora Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots
July 15, 2024
Kiora Pharmaceuticals and Théa Open Innovation Have Entered into a Development and Commercialization Agreement of ~ $301M
February 2, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.